Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Single-Handed Suturing Medical Device Developed By Mellon Medical


Medical Device

The Switch medical device has a range of applications, from stitching-up blood vessels to closing incisions made in the skin, and could save surgeons considerable time in the operating room.

Tweetables from this article:

Tweet: Mellon Medical's Switch #medicaldevice requires only a single hand to operate http://ctt.ec/FwI3h+ Mellon Medical's Switch medical device requires only a single hand to operate.

Share this!

October 5, 2016 | by Sarah Hand, M.Sc.

Closing a patient up after surgery is one of the most simple, yet time-consuming tasks performed by surgeons. Dutch medical device company, Mellon Medical, has set out to make this laborious process more efficient by developing their new suturing device, Switch, which requires only one hand to operate.

The Switch medical device has a range of applications, from stitching-up blood vessels to closing incisions made in the skin, and could save surgeons considerable time in the operating room. While the first iteration of this suturing medical device is 8 cm long and indicated for use during kidney transplants, peripheral bypass procedures and carotid artery surgery, the company plans to eventually release multiple sizes of the tool meant to perform different functions.

The medical device is designed to look like a pair of bent tweezers with a small needle and attached suture positioned directly at the tip of the Switch. With every manipulation of the tweezers, the needle is passed from one point to the other.

As the Switch requires only a single hand to operate, a surgeon’s non-dominant hand can be freed-up to perform other tasks such as presenting the tissue. Since the needle and attached suture are passed linearly between the tweezer tips, the surgeon does not need to focus on catching the needle as it passes through the tissue.

The result is a much more efficient way of suturing in the operating room. According to a press release issued by Mellon, the Switch is two times faster than conventional suturing methods.

As yet, the medical device is not approved by regulators, but Mellon plans to apply for both CE mark and US Food and Drug Administration (FDA) approval in the next several years. Their initial launch is set to be focused on vascular surgery but Mellon says the technology can be applied to a number of other disciplines, including neurosurgery, urology and gynecology.

Keywords: Medical Device, Surgery, FDA


Share this with your colleagues!

Better Meal Planning for Diabetics Using a Predictive Blood Sugar App

April 21, 2017 - A new app could allow people with type 2 diabetes to make predictions about the impact of a meal on their blood sugar levels, before they even take a bite.

Featured In: Life Science News

Bacterial Biomarkers Could Make Diagnosing Colorectal Cancer Less Invasive

April 20, 2017 - Researchers at The University of Texas Health Science Center at Houston School of Public Health have identified specific strains of gut bacteria which have been associated with colorectal cancer.

Featured In: Life Science News

Weetabix Cereal Sold to Post in £1.4 Billion Deal

April 20, 2017 - The cereal was sold by Shanghai-based Bright Food, which acquired a controlling stake in the company in 2012.

Featured In: Food News


What Medical Device Manufacturers Need to Know Before Developing a Biological Safety Evaluation


Electronic Informed Consent: 2017 Industry Survey Results

Critical CRO Oversight Metrics: How to Establish the Right Metrics and Monitor them in Real-Time

The Modernization of eCOA Technology for Clinical Trials

Developing a Biological Safety Evaluation

Copyright © 2016-2017 Honeycomb Worldwide Inc.